                         SEQUENCE LISTING

<110>  Health Research, Inc.
 
<120>  ANTI-SURVIVIN ANTIBODIES FOR TREATMENT OF AUTOIMMUNE DISEASES

<130>  003551.01011

<150>  63/132,964
<151>  2020-12-31

<160>  27    

<170>  PatentIn version 3.5

<210>  1
<211>  23
<212>  PRT
<213>  Homo sapiens

<400>  1

Glu Asn Glu Pro Asp Leu Ala Gln Cys Phe Phe Cys Phe Lys Glu Leu 
1               5                   10                  15      


Glu Gly Trp Glu Pro Asp Asp 
            20              


<210>  2
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  variant of SEQ ID NO:1 with a single amino acid change

<400>  2

Glu Asn Glu Pro Asp Leu Ala Gln Met Phe Phe Cys Phe Lys Glu Leu 
1               5                   10                  15      


Glu Gly Trp Glu Pro Asp Asp 
            20              


<210>  3
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  a six amino acid long fragment of SEQ ID NO:2.

<400>  3

Gln Met Phe Phe Cys Phe 
1               5       


<210>  4
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  a fifteen amino acid long fragment of SEQ ID NO:2 and comprises 
       the sequence of SEQ ID NO:3.

<400>  4

Asp Leu Ala Gln Met Phe Phe Cys Phe Lys Glu Leu Glu Gly Trp 
1               5                   10                  15  


<210>  5
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  a ten amino acid long fragment of SEQ ID NO:2 and comprises the 
       sequence of SEQ ID NO:3.

<400>  5

Ala Gln Met Phe Phe Cys Phe Lys Glu Leu 
1               5                   10  


<210>  6
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  a nine amino acid long fragment of SEQ ID NO:2 and comprises the 
       sequence of SEQ ID NO: 3.

<400>  6

Gln Met Phe Phe Cys Phe Lys Glu Leu 
1               5                   


<210>  7
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  an amino acid sequence for VH CDR1 for mAb 2C2E7.

<400>  7

Thr Tyr Gly Met Ser 
1               5   


<210>  8
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  an amino acid sequence for VH CDR2 for mAb 2C2E7.

<400>  8

Trp Ile Asn Pro Tyr Ser Gly Val Pro Thr Tyr Ala Val Asp Phe Lys 
1               5                   10                  15      


Gly 
    


<210>  9
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  an amino acid sequence for VH CDR3 for mAb 2C2E7.

<400>  9

Gly Gly Arg Arg Gly Asp Phe Gly Tyr 
1               5                   


<210>  10
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  an amino acid sequence for VL CDR1 for mAb 2C2E7.

<400>  10

Ser Ala Ser Ser Ser Ile Ser Tyr Met His 
1               5                   10  


<210>  11
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  an amino acid sequence for VL CDR2 for mAb 2C2E7.

<400>  11

Asp Thr Ser Lys Leu Ala Ser 
1               5           


<210>  12
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  an amino acid sequence for VL CDR3 for mAb 2C2E7.

<400>  12

His Gln Arg Ser Ser His His Thr 
1               5               


<210>  13
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  an amino acid sequence for VH CDR1 for mAb 30H3D2.

<400>  13

Ser Tyr Gly Met Ser 
1               5   


<210>  14
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  an amino acid sequence for VH CDR2 for mAb 30H3D2.

<400>  14

Thr Ile Ser Ser Gly Gly Ser His Thr Tyr Tyr Pro Asp Ser Val Arg 
1               5                   10                  15      


Gly 
    


<210>  15
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  an amino acid sequence for VH CDR3 for mAb 30H3D2.

<400>  15

His Pro Ile Tyr Tyr Tyr Ile Ser Ser Tyr Ala Met Asp Tyr 
1               5                   10                  


<210>  16
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  an amino acid sequence for VL CDR1 for mAb 30H3D2.

<400>  16

Arg Ser Ser Gln Ser Leu Val His Ser Thr Gly Asn Thr Tyr Leu His 
1               5                   10                  15      


<210>  17
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  an amino acid sequence for VL CDR2 for mAb 30H3D2.

<400>  17

Lys Val Ser Asn Arg Phe Ser 
1               5           


<210>  18
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  an amino acid sequence for VL CDR3 for mAb 30H3D2.

<400>  18

Ser Gln Ser Thr His Val Pro Pro Thr 
1               5                   


<210>  19
<211>  137
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  an amino acid sequence for heavy chain variable region from mAb 
       2C2E7.

<400>  19

Met Gly Trp Leu Trp Asn Leu Leu Phe Leu Met Ala Ala Ala Gln Ser 
1               5                   10                  15      


Ala Gln Ala Gln Ile Gln Leu Val Gln Ser Gly Pro Glu Leu Lys Lys 
            20                  25                  30          


Pro Gly Glu Thr Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe 
        35                  40                  45              


Thr Thr Tyr Gly Met Ser Trp Val Lys Gln Ala Pro Gly Arg Gly Leu 
    50                  55                  60                  


Lys Trp Met Gly Trp Ile Asn Pro Tyr Ser Gly Val Pro Thr Tyr Ala 
65                  70                  75                  80  


Val Asp Phe Lys Gly Arg Phe Ala Phe Ser Leu Glu Thr Ser Ala Ser 
                85                  90                  95      


Thr Ala Tyr Leu Gln Ile Asn Asn Leu Lys Asn Glu Asp Thr Ala Thr 
            100                 105                 110         


Tyr Phe Cys Ala Arg Gly Gly Arg Arg Gly Asp Phe Gly Tyr Trp Gly 
        115                 120                 125             


Gln Gly Thr Thr Leu Thr Val Ser Ser 
    130                 135         


<210>  20
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  an amino acid sequence for light chain variable region from mAb 
       2C2E7.

<400>  20

Met Asp Phe Gln Val Gln Ile Phe Ser Phe Leu Leu Ile Ser Ala Ser 
1               5                   10                  15      


Val Ile Leu Ser Ser Gly Gln Ile Gly Leu Thr Gln Ser Pro Ala Ile 
            20                  25                  30          


Met Ser Ala Ser Pro Gly Glu Lys Val Thr Met Thr Cys Ser Ala Ser 
        35                  40                  45              


Ser Ser Ile Ser Tyr Met His Trp Tyr Gln Gln Lys Pro Gly Thr Ser 
    50                  55                  60                  


Pro Lys Thr Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser Gly Val Pro 
65                  70                  75                  80  


Ala Arg Phe Ser Gly Ser Gly Ser Gly Thr Ser Tyr Ser Leu Thr Ile 
                85                  90                  95      


Ser Ser Met Glu Ala Glu Asp Ala Ala Thr Tyr Tyr Cys His Gln Arg 
            100                 105                 110         


Ser Ser His His Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys 
        115                 120                 125         


<210>  21
<211>  142
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  an amino acid sequence for heavy chain variable region from mAb 
       30H3D2.

<400>  21

Met Asn Phe Gly Leu Ser Leu Ile Phe Leu Ala Leu Ile Leu Lys Gly 
1               5                   10                  15      


Val Gln Cys Glu Val Gln Leu Val Glu Ser Gly Gly Asp Leu Val Lys 
            20                  25                  30          


Pro Gly Gly Ser Leu Lys Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe 
        35                  40                  45              


Ser Ser Tyr Gly Met Ser Trp Val Arg Leu Thr Pro Asp Lys Arg Leu 
    50                  55                  60                  


Glu Trp Val Ala Thr Ile Ser Ser Gly Gly Ser His Thr Tyr Tyr Pro 
65                  70                  75                  80  


Asp Ser Val Arg Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn 
                85                  90                  95      


Thr Leu Tyr Leu Gln Met Ser Ser Leu Lys Ser Glu Asp Thr Ala Met 
            100                 105                 110         


Tyr Tyr Cys Ala Arg His Pro Ile Tyr Tyr Tyr Ile Ser Ser Tyr Ala 
        115                 120                 125             


Met Asp Tyr Trp Gly Gln Gly Thr Ser Val Thr Val Ser Ser 
    130                 135                 140         


<210>  22
<211>  131
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  an amino acid sequence for light chain variable region from mAb 
       30H3D2.

<400>  22

Met Lys Leu Pro Val Arg Leu Leu Val Leu Met Phe Trp Ile Pro Ala 
1               5                   10                  15      


Ser Ser Ser Asp Val Val Met Thr Gln Thr Pro Leu Ser Leu Pro Val 
            20                  25                  30          


Ser Leu Gly Asp Gln Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu 
        35                  40                  45              


Val His Ser Thr Gly Asn Thr Tyr Leu His Trp Tyr Leu Gln Lys Pro 
    50                  55                  60                  


Gly Gln Ser Pro Lys Leu Leu Ile Tyr Lys Val Ser Asn Arg Phe Ser 
65                  70                  75                  80  


Gly Val Pro Asp Arg Phe Gly Gly Ser Gly Ser Gly Thr Asp Phe Thr 
                85                  90                  95      


Leu Lys Ile Ser Arg Val Glu Ala Glu Asp Leu Gly Val Tyr Phe Cys 
            100                 105                 110         


Ser Gln Ser Thr His Val Pro Pro Thr Phe Gly Gly Gly Thr Lys Leu 
        115                 120                 125             


Glu Ile Lys 
    130     


<210>  23
<211>  411
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  a nucleotide sequence encoding the heavy chain variable region of
       2C2E7 (it encodes the amino acid sequence of SEQ ID NO:19).

<400>  23

Ala Thr Gly Gly Gly Thr Thr Gly Gly Cys Thr Gly Thr Gly Gly Ala 
1               5                   10                  15      


Ala Cys Thr Thr Gly Cys Thr Ala Thr Thr Cys Cys Thr Gly Ala Thr 
            20                  25                  30          


Gly Gly Cys Ala Gly Cys Thr Gly Cys Cys Cys Ala Ala Ala Gly Thr 
        35                  40                  45              


Gly Cys Cys Cys Ala Ala Gly Cys Ala Cys Ala Gly Ala Thr Cys Cys 
    50                  55                  60                  


Ala Gly Thr Thr Gly Gly Thr Ala Cys Ala Ala Thr Cys Thr Gly Gly 
65                  70                  75                  80  


Ala Cys Cys Thr Gly Ala Gly Cys Thr Gly Ala Ala Gly Ala Ala Gly 
                85                  90                  95      


Cys Cys Thr Gly Gly Ala Gly Ala Gly Ala Cys Ala Gly Thr Cys Ala 
            100                 105                 110         


Ala Gly Ala Thr Cys Thr Cys Cys Thr Gly Cys Ala Ala Gly Gly Cys 
        115                 120                 125             


Thr Thr Cys Thr Gly Gly Gly Thr Ala Thr Ala Cys Cys Thr Thr Cys 
    130                 135                 140                 


Ala Cys Ala Ala Cys Cys Thr Ala Thr Gly Gly Ala Ala Thr Gly Ala 
145                 150                 155                 160 


Gly Cys Thr Gly Gly Gly Thr Gly Ala Ala Ala Cys Ala Gly Gly Cys 
                165                 170                 175     


Thr Cys Cys Ala Gly Gly Ala Ala Gly Gly Gly Gly Thr Thr Thr Ala 
            180                 185                 190         


Ala Ala Gly Thr Gly Gly Ala Thr Gly Gly Gly Cys Thr Gly Gly Ala 
        195                 200                 205             


Thr Ala Ala Ala Cys Cys Cys Cys Thr Ala Cys Thr Cys Thr Gly Gly 
    210                 215                 220                 


Ala Gly Thr Gly Cys Cys Ala Ala Cys Ala Thr Ala Thr Gly Cys Thr 
225                 230                 235                 240 


Gly Thr Thr Gly Ala Cys Thr Thr Cys Ala Ala Gly Gly Gly Ala Cys 
                245                 250                 255     


Gly Gly Thr Thr Thr Gly Cys Cys Thr Thr Cys Thr Cys Thr Thr Thr 
            260                 265                 270         


Gly Gly Ala Ala Ala Cys Cys Thr Cys Thr Gly Cys Cys Ala Gly Cys 
        275                 280                 285             


Ala Cys Thr Gly Cys Cys Thr Ala Thr Thr Thr Gly Cys Ala Gly Ala 
    290                 295                 300                 


Thr Cys Ala Ala Cys Ala Ala Cys Cys Thr Cys Ala Ala Ala Ala Ala 
305                 310                 315                 320 


Thr Gly Ala Gly Gly Ala Cys Ala Cys Gly Gly Cys Thr Ala Cys Ala 
                325                 330                 335     


Thr Ala Thr Thr Thr Cys Thr Gly Thr Gly Cys Ala Ala Gly Ala Gly 
            340                 345                 350         


Gly Ala Gly Gly Gly Cys Gly Gly Ala Gly Gly Gly Gly Gly Gly Ala 
        355                 360                 365             


Cys Thr Thr Thr Gly Gly Cys Thr Ala Cys Thr Gly Gly Gly Gly Cys 
    370                 375                 380                 


Cys Ala Ala Gly Gly Cys Ala Cys Cys Ala Cys Thr Cys Thr Cys Ala 
385                 390                 395                 400 


Cys Ala Gly Thr Cys Thr Cys Cys Thr Cys Ala 
                405                 410     


<210>  24
<211>  381
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  a nucleotide sequence encoding the light chain variable region of
       2C2E7 (it encodes the amino acid sequence of SEQ ID NO:20).

<400>  24

Ala Thr Gly Gly Ala Thr Thr Thr Thr Cys Ala Gly Gly Thr Gly Cys 
1               5                   10                  15      


Ala Gly Ala Thr Thr Thr Thr Cys Ala Gly Cys Thr Thr Cys Cys Thr 
            20                  25                  30          


Gly Cys Thr Ala Ala Thr Cys Ala Gly Thr Gly Cys Cys Thr Cys Ala 
        35                  40                  45              


Gly Thr Cys Ala Thr Ala Cys Thr Gly Thr Cys Cys Ala Gly Cys Gly 
    50                  55                  60                  


Gly Ala Cys Ala Ala Ala Thr Thr Gly Gly Thr Cys Thr Cys Ala Cys 
65                  70                  75                  80  


Cys Cys Ala Gly Thr Cys Thr Cys Cys Ala Gly Cys Ala Ala Thr Cys 
                85                  90                  95      


Ala Thr Gly Thr Cys Thr Gly Cys Ala Thr Cys Thr Cys Cys Ala Gly 
            100                 105                 110         


Gly Gly Gly Ala Gly Ala Ala Gly Gly Thr Cys Ala Cys Cys Ala Thr 
        115                 120                 125             


Gly Ala Cys Cys Thr Gly Cys Ala Gly Thr Gly Cys Cys Ala Gly Cys 
    130                 135                 140                 


Thr Cys Ala Ala Gly Thr Ala Thr Ala Ala Gly Thr Thr Ala Cys Ala 
145                 150                 155                 160 


Thr Gly Cys Ala Thr Thr Gly Gly Thr Ala Cys Cys Ala Gly Cys Ala 
                165                 170                 175     


Gly Ala Ala Gly Cys Cys Ala Gly Gly Cys Ala Cys Cys Thr Cys Cys 
            180                 185                 190         


Cys Cys Cys Ala Ala Ala Ala Cys Ala Thr Gly Gly Ala Thr Thr Thr 
        195                 200                 205             


Ala Thr Gly Ala Cys Ala Cys Ala Thr Cys Cys Ala Ala Ala Cys Thr 
    210                 215                 220                 


Gly Gly Cys Thr Thr Cys Thr Gly Gly Ala Gly Thr Cys Cys Cys Thr 
225                 230                 235                 240 


Gly Cys Thr Cys Gly Cys Thr Thr Cys Ala Gly Thr Gly Gly Cys Ala 
                245                 250                 255     


Gly Thr Gly Gly Gly Thr Cys Thr Gly Gly Gly Ala Cys Cys Thr Cys 
            260                 265                 270         


Thr Thr Ala Thr Thr Cys Thr Cys Thr Cys Ala Cys Ala Ala Thr Cys 
        275                 280                 285             


Ala Gly Cys Ala Gly Cys Ala Thr Gly Gly Ala Gly Gly Cys Thr Gly 
    290                 295                 300                 


Ala Ala Gly Ala Thr Gly Cys Thr Gly Cys Cys Ala Cys Thr Thr Ala 
305                 310                 315                 320 


Thr Thr Ala Cys Thr Gly Cys Cys Ala Thr Cys Ala Gly Cys Gly Gly 
                325                 330                 335     


Ala Gly Thr Ala Gly Thr Cys Ala Cys Cys Ala Cys Ala Cys Gly Thr 
            340                 345                 350         


Thr Cys Gly Gly Ala Gly Gly Gly Gly Gly Gly Ala Cys Cys Ala Ala 
        355                 360                 365             


Gly Cys Thr Gly Gly Ala Ala Ala Thr Ala Ala Ala Ala 
    370                 375                 380     


<210>  25
<211>  426
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  a nucleotide sequence encoding the heavy chain variable region of
       30H3D2 (it encodes the amino acid sequence of SEQ ID NO:21).

<400>  25

Ala Thr Gly Ala Ala Cys Thr Thr Cys Gly Gly Gly Cys Thr Cys Ala 
1               5                   10                  15      


Gly Cys Thr Thr Gly Ala Thr Thr Thr Thr Cys Cys Thr Thr Gly Cys 
            20                  25                  30          


Cys Cys Thr Thr Ala Thr Thr Thr Thr Ala Ala Ala Ala Gly Gly Thr 
        35                  40                  45              


Gly Thr Cys Cys Ala Gly Thr Gly Thr Gly Ala Gly Gly Thr Gly Cys 
    50                  55                  60                  


Ala Gly Cys Thr Gly Gly Thr Gly Gly Ala Gly Thr Cys Thr Gly Gly 
65                  70                  75                  80  


Gly Gly Gly Ala Gly Ala Cys Thr Thr Ala Gly Thr Gly Ala Ala Gly 
                85                  90                  95      


Cys Cys Thr Gly Gly Ala Gly Gly Gly Thr Cys Cys Cys Thr Gly Ala 
            100                 105                 110         


Ala Ala Cys Thr Cys Thr Cys Cys Thr Gly Thr Gly Cys Ala Gly Cys 
        115                 120                 125             


Cys Thr Cys Thr Gly Gly Ala Thr Thr Cys Ala Cys Thr Thr Thr Cys 
    130                 135                 140                 


Ala Gly Thr Ala Gly Cys Thr Ala Thr Gly Gly Cys Ala Thr Gly Thr 
145                 150                 155                 160 


Cys Thr Thr Gly Gly Gly Thr Thr Cys Gly Cys Cys Thr Gly Ala Cys 
                165                 170                 175     


Thr Cys Cys Ala Gly Ala Cys Ala Ala Gly Ala Gly Gly Cys Thr Gly 
            180                 185                 190         


Gly Ala Gly Thr Gly Gly Gly Thr Cys Gly Cys Ala Ala Cys Cys Ala 
        195                 200                 205             


Thr Thr Ala Gly Cys Ala Gly Thr Gly Gly Thr Gly Gly Thr Ala Gly 
    210                 215                 220                 


Thr Cys Ala Cys Ala Cys Cys Thr Ala Cys Thr Ala Thr Cys Cys Ala 
225                 230                 235                 240 


Gly Ala Cys Ala Gly Thr Gly Thr Gly Ala Gly Gly Gly Gly Gly Cys 
                245                 250                 255     


Gly Ala Thr Thr Cys Ala Cys Cys Ala Thr Cys Thr Cys Cys Ala Gly 
            260                 265                 270         


Ala Gly Ala Cys Ala Ala Thr Gly Cys Cys Ala Ala Gly Ala Ala Cys 
        275                 280                 285             


Ala Cys Cys Cys Thr Gly Thr Ala Cys Cys Thr Gly Cys Ala Ala Ala 
    290                 295                 300                 


Thr Gly Ala Gly Cys Ala Gly Thr Cys Thr Gly Ala Ala Gly Thr Cys 
305                 310                 315                 320 


Thr Gly Ala Gly Gly Ala Cys Ala Cys Ala Gly Cys Cys Ala Thr Gly 
                325                 330                 335     


Thr Ala Thr Thr Ala Cys Thr Gly Thr Gly Cys Ala Ala Gly Ala Cys 
            340                 345                 350         


Ala Cys Cys Cys Ala Ala Thr Thr Thr Ala Thr Thr Ala Cys Thr Ala 
        355                 360                 365             


Cys Ala Thr Thr Ala Gly Thr Ala Gly Cys Thr Ala Thr Gly Cys Thr 
    370                 375                 380                 


Ala Thr Gly Gly Ala Cys Thr Ala Cys Thr Gly Gly Gly Gly Thr Cys 
385                 390                 395                 400 


Ala Ala Gly Gly Ala Ala Cys Cys Thr Cys Ala Gly Thr Cys Ala Cys 
                405                 410                 415     


Cys Gly Thr Cys Thr Cys Cys Thr Cys Ala 
            420                 425     


<210>  26
<211>  393
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  a nucleotide sequence encoding the light chain variable region of
       30H3D2 (it encodes the amino acid sequence of SEQ ID NO:22).

<400>  26

Ala Thr Gly Ala Ala Gly Thr Thr Gly Cys Cys Thr Gly Thr Thr Ala 
1               5                   10                  15      


Gly Gly Cys Thr Gly Thr Thr Gly Gly Thr Gly Cys Thr Gly Ala Thr 
            20                  25                  30          


Gly Thr Thr Cys Thr Gly Gly Ala Thr Thr Cys Cys Thr Gly Cys Thr 
        35                  40                  45              


Thr Cys Cys Ala Gly Cys Ala Gly Thr Gly Ala Thr Gly Thr Thr Gly 
    50                  55                  60                  


Thr Gly Ala Thr Gly Ala Cys Cys Cys Ala Ala Ala Cys Thr Cys Cys 
65                  70                  75                  80  


Ala Cys Thr Cys Thr Cys Cys Cys Thr Gly Cys Cys Thr Gly Thr Cys 
                85                  90                  95      


Ala Gly Thr Cys Thr Thr Gly Gly Ala Gly Ala Thr Cys Ala Ala Gly 
            100                 105                 110         


Cys Cys Thr Cys Cys Ala Thr Cys Thr Cys Thr Thr Gly Cys Ala Gly 
        115                 120                 125             


Ala Thr Cys Thr Ala Gly Thr Cys Ala Gly Ala Gly Cys Cys Thr Thr 
    130                 135                 140                 


Gly Thr Ala Cys Ala Cys Ala Gly Thr Ala Cys Thr Gly Gly Ala Ala 
145                 150                 155                 160 


Ala Cys Ala Cys Cys Thr Ala Thr Thr Thr Ala Cys Ala Thr Thr Gly 
                165                 170                 175     


Gly Thr Ala Cys Cys Thr Gly Cys Ala Gly Ala Ala Gly Cys Cys Ala 
            180                 185                 190         


Gly Gly Cys Cys Ala Gly Thr Cys Thr Cys Cys Ala Ala Ala Gly Cys 
        195                 200                 205             


Thr Cys Cys Thr Gly Ala Thr Cys Thr Ala Cys Ala Ala Ala Gly Thr 
    210                 215                 220                 


Thr Thr Cys Cys Ala Ala Cys Cys Gly Ala Thr Thr Thr Thr Cys Thr 
225                 230                 235                 240 


Gly Gly Gly Gly Thr Cys Cys Cys Ala Gly Ala Cys Ala Gly Gly Thr 
                245                 250                 255     


Thr Cys Gly Gly Thr Gly Gly Cys Ala Gly Thr Gly Gly Ala Thr Cys 
            260                 265                 270         


Ala Gly Gly Gly Ala Cys Ala Gly Ala Thr Thr Thr Cys Ala Cys Ala 
        275                 280                 285             


Cys Thr Cys Ala Ala Gly Ala Thr Cys Ala Gly Cys Ala Gly Ala Gly 
    290                 295                 300                 


Thr Gly Gly Ala Gly Gly Cys Thr Gly Ala Gly Gly Ala Thr Cys Thr 
305                 310                 315                 320 


Gly Gly Gly Ala Gly Thr Thr Thr Ala Thr Thr Thr Cys Thr Gly Cys 
                325                 330                 335     


Thr Cys Thr Cys Ala Ala Ala Gly Thr Ala Cys Ala Cys Ala Thr Gly 
            340                 345                 350         


Thr Thr Cys Cys Thr Cys Cys Gly Ala Cys Gly Thr Thr Cys Gly Gly 
        355                 360                 365             


Thr Gly Gly Ala Gly Gly Cys Ala Cys Cys Ala Ala Gly Cys Thr Gly 
    370                 375                 380                 


Gly Ala Ala Ala Thr Cys Ala Ala Ala 
385                 390             


<210>  27
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  a fifteen amino acid long fragment of human survivin.

<400>  27

Asp Leu Ala Gln Cys Phe Phe Cys Phe Lys Glu Leu Glu Gly Trp 
1               5                   10                  15  


